4.1 Therapeutic indications
In the management of:
• Angina pectoris
• Cardiac arrhythmias(in particular supraventricular tachycardias)
• As an adjunctive treatment of thyrotoxicosis.
• Early intervention of metoprolol tartrate in acute myocardial infarction reduces infarct size and the incidence of ventricular fibrillation. Pain relief may also decrease the need for opiate analgesics.
• long-term prophylaxis after recovery from acute myocardial infarction.
• Prophylaxis of migraine
Metoprolol tartrate has been shown to reduce mortality when administered to patients with acute myocardial infarction.
Metoprolol is indicated in adults.
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).